Certain confidential portions (indicated by brackets and asterisks) have been omitted from this exhibit in accordance with the rules of the Securities and Exchange Commission. DP220039 Andrew SimsCancer Research Grant Contract • September 22nd, 2022 • Plus Therapeutics, Inc. • Surgical & medical instruments & apparatus • Texas
This CANCER RESEARCH GRANT CONTRACT (“Contract”) is by and between the Cancer Prevention and Research Institute of Texas (“CPRIT”), hereinafter referred to as the “INSTITUTE”, acting through its Chief Executive Officer, and PLUS Therapeutics, Inc., hereinafter referred to as the “RECIPIENT”, acting through its authorized signing official.
